This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Herbalife Investors Unmoved by Ackman's China Claims

Stocks in this article: HLF

NEW YORK ( TheStreet) -- With shares of Herbalife (HLF - Get Report) climbing well over 5% this morning to $69.05, Wall Street apparently does not cares about Bill Ackman's recent complaints.

Aside from being a notable short, Ackman insists that the nutrition and weight-loss company is a "pyramid scheme." Ackman has had a long battle with Herbalife.

On Tuesday, the activist investor launched a few more attacks. According to Bloomberg, Ackman, along with his firm Pershing Square Capital Management LP, hired OTG Research to evaluate Herbalife's China operations.

Ackman says the investigation discovered that illegal payments were made to people by Herbalife, based on the number of new recruits they're able to bring to the company. If true, this would breach direct-selling laws in China.

During Tuesday's two-hour presentation, Ackman said of Herbalife, "They defraud millions of people." Ackman then continued, "Their portrayal of their China business in their SEC filings is materially false and misleading."

Herbalife is not taking these accusations lightly. In response to Ackman, the company said:

"Herbalife remains confident in its business in China, which is built on customers enjoying and benefiting from our nutrition products each and every day."

Herbalife continued:

"We will continue to invest in this important market and collaborate with the Chinese government to deliver high-quality nutrition to the Chinese consumer through lawful direct-selling practices."

And regarding Ackman's presentation, Herbalife insists that the only thing it accomplished was to reveal Ackman's "continued failure to fundamentally understand Herbalife's business model."

So what's an investor to do in this situation?

We have no way of knowing whether Ackman's thesis is true. The truth may come to light somewhere down the road. But as it stands, it's his word against Herbalife's.

It also can't be ignored that Ackman wants to be right on his short position. After all, he has a price target on the stock of $0 and is bearish roughly 20 million shares.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs